Headline:
FDA clears Lynparza for prostate cancer treatment
Publication Date:
Wednesday, June 7, 2023
Primary Source:
Type:
article
Format:
New Media
Nature of Mention:
featured
Scholar:
Research Area:
Subjects:
Custom Description:
National Desk new media post featuring Jeffrey Singer on the FDA's approval of Lynparza reprinted at cbsaustin.com (Austin TX): "FDA clears Lynparza for prostate cancer treatment"